DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Parnaparin is an investigational drug.
There have been 3 clinical trials for Parnaparin. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2006.
The most common disease conditions in clinical trials are Venous Thrombosis, Thrombosis, and Thrombophlebitis. The leading clinical trial sponsors are Università degli Studi dell'Insubria, Alfa Wassermann, Bologna, Italy, and St. Orsola Hospital.
Recent Clinical Trials for Parnaparin
|Weight Adjusted Low Molecular Weight Heparin in Recurrent Implantation Failure: a Randomized Open Labeled Trial||Istituto Clinico Humanitas||Phase 3|
|Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis||St. Orsola Hospital||Phase 3|
|Parnaparin vs Aspirin in the Treatment of Retinal Vein Occlusion||Alfa Wassermann, Bologna, Italy||Phase 3|